Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 3 Low-grade inflammation in FGID

Published byJerome Walton Modified over 6 years ago

Similar presentations

Presentation on theme: "Figure 3 Low-grade inflammation in FGID"— Presentation transcript:

1 Figure 3 Low-grade inflammation in FGID
Figure 3 | Low-grade inflammation in FGID. a | Increased numbers of tryptase-positive mast cells (brown staining) in the colon of patients with IBS. b | Expansion of duodenal eosinophils in the duodenal mucosa of patient with functional dyspepsia. c | Eosinophil degranulation in duodenal mucosa of a patient with functional dyspepsia (carbol chromotrope stain, arrow) adjacent to nerves (S100 immunostaining, arrowhead). Inset: intact eosinophil. Magnification for parts a and b ×20, for part c ×40 and inset ×100. FGID, functional gastrointestinal disorder. Powell, N. et al. (2017) The mucosal immune system: master regulator of bidirectional gut–brain communications Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Download ppt "Figure 3 Low-grade inflammation in FGID"

Similar presentations

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 2 Endoscopic imaging of intestinal villi

Figure 2 Endoscopic imaging of intestinal villi
Figure 4 The gut microbiota directly influences T-cell differentiation

Figure 4 The gut microbiota directly influences T-cell differentiation
Figure 1 Imaging of a depressed intramucosal carcinoma

Figure 1 Imaging of a depressed intramucosal carcinoma
Figure 4 Activation of clopidogrel via cytochrome P450

Figure 4 Activation of clopidogrel via cytochrome P450
Figure 5 Therapeutic paradigms for interfering with the brain–gut axis

Figure 5 Therapeutic paradigms for interfering with the brain–gut axis
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 6 Injection of mesenchymal stem cells in perianal fistulas

Figure 6 Injection of mesenchymal stem cells in perianal fistulas
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 2 The microbiome–gut–brain axis

Figure 2 The microbiome–gut–brain axis
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 3 The T-cell cytokine tree in IBD

Figure 3 The T-cell cytokine tree in IBD
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 1 Biosimilar development process

Figure 1 Biosimilar development process
Figure 3 Histological subtypes of intrahepatic CCA

Figure 3 Histological subtypes of intrahepatic CCA
Figure 3 The 'leaky gut' hypothesis

Figure 3 The 'leaky gut' hypothesis
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Similar presentations

Ads by Google